Device Instruments

Mild Device Kit

Payments companies reported to CMS as associated with Mild Device Kit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.5Massociated payments (2023-2025)
5,699clinicians with associated payments
3companies reporting

By year

2023 $951K
2024 $1.2M
2025 $1.4M

Payments reported as associated with Mild Device Kit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine (Anesthesiology) $909K
Interventional Pain Medicine $676K
Pain Medicine $334K
Pain Medicine (Physical Medicine & Rehabilitation) $225K
Orthopaedic Surgery $219K
Neurological Surgery $169K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Mild Device Kit

These are the largest totals companies reported as associated with Mild Device Kit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Peter Pryzbylkowski Philadelphia, PA Pain Medicine $144,997.58
Vishal Khemlani Tualatin, OR Pain Medicine (Anesthesiology) $112,270.49
Jason Williams Boise, ID Pain Medicine (Anesthesiology) $100,677.00
David Dickerson Evanston, IL Pain Medicine (Anesthesiology) $100,375.12
Denis Patterson Reno, NV Pain Medicine (Physical Medicine & Rehabilitation) $95,989.50
Alexander Escobar Toledo, OH Pain Medicine $95,892.45
Rayhan Tariq Laurel, MS Pain Medicine (Anesthesiology) $86,612.09
Rebecca Sanders Joplin, MO Interventional Pain Medicine $80,718.86
Stanley Golovac Merritt Island, FL Interventional Pain Medicine $78,354.42
Harry Sukumaran Rochester Hills, MI Pain Medicine (Anesthesiology) $77,735.42

Prescribed Mild Device Kit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.